DAFTAR PUSTAKA

Abboud et al. (2012). Autonomic Neural Regulation of the Immune System: Implications for Hypertension and Cardiovascular Disease. Hypertension 59(4): 755762.

Ajmo Jr CT, Vernon DOL, Collier L, Hall AA, Davis SA, Wiling A, Pennypacker KR. (2008). The Spleen Contributes to Stroke-Induced Neurodegeneration. J Neurosci Res 86(10): 2227-2234.

Akiyoshi K, Dziennis S, Palmateer J, Ren X, Vandenbark AA, Offner H, Herson PS, Hurn PD (2011) Recombinant Tcell receptor ligands improve outcome after experimental cerebral ischemia. Transl Stroke Res 2:404-10.

Alvarez S, Blanco A, Fresno M, et al. (2011). TNF-a Contributes to Caspase-3 Independent Apoptosis in Neuroblastoma Cells: Role of NFAT. PLoS ONE 6(1): 1-13.

Amiya E, Watanabe M, Komuro I. (2014). The Relationship between Vascular Function

and the Autonomic Nervous System. Ann Vasc Dis 7(2): 109119.

Andersson U, Tracey KJ. (2012). Neural reflexes in inflammation and immunity. The Journal of Experimental Medicine 6: 1057-1068.

Antonioli et al (2012). Neuroimmune endocrine effects of antidepressants. Neuropsychiatric Disease and Treatment 8: 6583.

Arpd Dobolyi;Vincze, Csilla;Pl, Gabriella and Lovas, Gbor. (2012). The Neuroprotective Functions of Transforming Growth Factor Beta Proteins. International Journal of Molecular Sciences13: 8219-8258.

Arslan F, Keogh B, Mc Guirk P, Parker AE. (2010). TLR 2 and TLR4 in ischemia reperfusion injury. Mediators inflammation 2010: 7042-02.

Aslanyan S et al. (2004). GAIN International Steering Committee and Investigator. Poststroke neurological improvement within 7 days is associated with subsequent deterioration. Stroke. 35:2165-70.

Bamford et al. (1991). Classification and natural history of clinically identifiable subtypes of cerebral infarction. Lancet. 1991;337:1521-26.

Banerjee et al. (2013). Phenotypic changes in immune cell subsets reflect increased infarct volume in male vs. female mice. Transl Stroke Res 1: 4(5).

Bao Y, Kim E, Bhosle S, Mehta H, Cho S. (2010). A role for spleen monocytes in post-ischemic brain inflammation and injury. Journal of Neuroinflammation7:92.

Baune, Bernhard T; Konrad, Carsten; Grotegerd, Dominik; et al. (2012). Interleukin-6 gene (IL-6): a possible role in brain morphology in the healthy adult brain. Baune et al. Journal of Neuroinflammation 2012, 9:125.

Becker DE. (2012). Basic and clinical phamacology of autonomic drugs. Continuing Education 59: 159-169.

Bellinger DL, Millar BA, Perez S, Carter J, Wood C, ThyagaRajan S, Molinaro C, Lubahn C, Lorton D. (2008). Sympathetic Modulation of Immunity Relevance to Disease. Cell Immunol 252(1-2): 27-56.

Benakis, Corrine; Vaslin, Anne; Pasquali, christian; Hirt, Lorenz. (2012). Neuroprotection by inhibiting the c-Jun N-terminal kinase pathway after cerebral ischemia occurs independently of interleukin-6 and keratinocyte-derived chemokine (KC/CXCL1) secretion. Benakis et al. Journal of Neuroinflammation 2012, 9:76.

Bencherif et al. (2012). Alpha7 nicotinic receptors as novel therapeutic targets for inflammation-based diseases. Cell Mol Life Sci 68(6): 931949.

Blalock JE, and Smith EM. (2007). Conceptual development of the immune system as a sixth sense. Brain, Behavior, and Immunity 2333.

Bodhankar et al. (2013). IL-10-producing B-cells limit CNS inflammation and infarct volume in experimental stroke. Metab Brain Dis 28(3): 375386.

Bonilla LG, Benakis C, Moore J, Ladecola C, Anrather J: Immune mechanisms incerebral ischemic tolerance. Frontiers in Cellular Neuroscience. 2014, 8: 19

Borlongan CV. (2011). Bone marrow stem cell mobilization in stroke a bonehead may be good for all. Leukemia 25(11): 1674-1686.

Brait, Vanessa H; Arumugan, Thiruma V; Drummond, Grant R and Sobey, Christopher G (2012). Importance of T lymphocytes in brain injury, immunodeficiency, and recovery after cerebral ischemia. Journal of Cerebral Blood Flow & Metabolism. 32, 598611.

Brmer, Dirk; Hoyer, Heike; Gnther, Albrecht; Nowack, Samuel; Brunkhorst, Frank M; Witte, Otto W and Dirk Hoyer (2014). Study protocol: prediction of stroke associated infections by markers of autonomic control. BMC Neurology, 14:9.

Brea D, Blanco M; Ramos-Cabrer P, Moldes O; Arias S, Perez-Mato M; Leira R, Sobrino T and Castillo J (2011). Toll-like receptors 2 and 4 in ischemic stroke: outcome and therapeutic values. Journal of Cerebral Blood Flow & Metabolism. 31, 14241431.

British Hypertension Society. (2000). Beta-Adrenoceptor Antagonist (Beta-Blocker).

Bruno RM, Ghiadoni L, Delloro R, Seravello G, Taddei S, Grassi G. (2012). Sympathetic regulation of vascular function in health and disease. Frontiers in Neurology 3:1-15.

Buttner et al. (1997). S-100 Protein: Serum Marker of Focal Brain Damage after Ischemic Territorial MCA Infarction. 28(10): 1961-5.

Cai PY, Bodhit A, Ansani S, Halil FA, Thenkabail S, Saravanapavan P, Waters MF, Bidari S: Vagus nerve stimulation in ischemic stroke. (2014). old wine in a new bottle. Frontiers in Cellular Neuroscience 5: 8.

Camicioli R, Wild K. (1997). Assessment of the elderly with dementia. In: Herndon RM (ed). Handbook of neurologic rating scales. New York: Demos Vermade. p.129-31.

Chamorro A, Amaro S, Vargas M, Obach V,Cervera A, Torres F, et al. (2006). Interleukin 10, monocytes and increased risk of early infection in ischemic stroke. Journal of Neurology, neurosurgery, and psychiatry 77: 1279-1281.

Chamorro A, Urra X, et al. (2007). Infection After Acute Ischemic Stroke. A Manifestation of Brain Induced Immunodepression. Journal of Neurology, neurosurgery, and psychiatry 38:1097-1103

Chang and Lu (2012). Hiccup: Mystery, Nature and Treatment. J Neurogastroenterol Motil. 18:123 130.

Chen J,Venkat P,Zacharek A, Chopp M (2014). Neurorestorative therapy for stroke. Frontiers in Human Neuroscience. 8(382): 1-12.

Chen S, Wu H, Klebe D, Hong Y, Zhang J, Tang J. (2013). Regulatory T Cell in Stroke: A New Paradigm for Immune Regulation. Clinical and Developmental Immunology 1:9.

Cherry JD, Olschowka JA, OBanion MK. (2014). Neuroinflammation and M2 Microglia: The Good, The Bad , and The Inflamed. BioMed Central 11:98.

Chiarella; Soberanes S, Urich D; Morales-Nebreda L, Nigdelioglu R; Green D, Young; Gonzalez A, Rosario; Misharin, Ghio; Wunderink, Donnelly; Radigan, Perlman; Chandel, Budinger, and Mutlu. (2014). 2-Adrenergic agonists augment air pollutioninduced IL-6 release and thrombosis. The Journal of Clinical Investigation.

Chiu et al. Neurogenic Inflammation The Peripheral Nervous Systems Role in Host Defense and Immunopathology. (2012). Nat Neurosci. 15(8): 10631067.

Clark WN, Hourihane JM. (1997). Clinical stroke scales. in: Herndon RM (ed). Handbook of neurologic rating scales. New York: Demos Vermande. p.161-84.

Damian G. Deavall et al. (2012). Drug-Induced Oxidative Stress and Toxicity. Hindawi Publishing Corporation Journal of Toxicology.

Del Zoppo GJ, Sharp FR, Heiss WD, Albers GW.(2011). Heterogeneity in the penumbra. Journal of cerebral blood flow and metabolism: official journal of the International Society of Cerebral Blood Flow and Metabolism 31: 1836-1851.

Del Zoppo et al. (2013). Hemostasis and Alterations of the Central Nervous System. Semin Thromb Hemost 39(8): 856875.

Deplanque D et al. (2006). Prior TIA, lipid lowering drug use, and physical activity decrease ischemic stroke severity. Neurology. 67:1403-10.

Doll DN, Barr TL, Simpkins JW. (2014). Cytokines: Their Role in Stroke and Potential Use as Biomarkers and therapeutic Targets. Aging and Disease 5: 294-306.

Donnan AC et al. (2007). The ischemic penumbra: overview, definition, and criteria. p. 1-20.

Downes CE, Crack PJ. (2010). Neural injury following stroke: are Toll-like receptors the link between the immune system and the CNS?. British Journal of Pharmacology 160: 18721888.

Doze, Van A. And Perez, Dianne M. (2012). G-Protein-Coupled Receptors in Adult Neurogenesis.Pharmacological Reviews. 64:645675.

Dunn AJ. (2006). Effects of cytokines and infections on brain neurochemistry. Clin Neurosci Res 6(1-2): 52-68.

Dziennis S and Alkayed NJ. (2008). Role of Signal Transducer and Activator of Transcription 3 in Neuronal Survival and Regeneration. Rev Neurosci 19(4-5): 341361.

Dziennis S, Marker S, Akiyoshi K, Ren X, Ayala P, Burrows GG, Vandenbark AA, Herson PS, Hurn PD, Offner HA. (2011). Therapy with recombinant T-cell reseptor ligand reduces infract size and infiltrating inflammatory cells in brain after middle cerebral artery occlution in mice. Metab Brain Dis 26: 123-33.

Dziewulska D, Mossakowski MJ (2003). Cellular expression of tumor necrosis factor and its receptors in human ischemic stroke. Clinical Neuropathology 22: 35-40.

E Tarkowski et al. (1997). Intrathecal release of pro- and anti-inflammatory cytokines during stroke. Clin Exp Immunol 110:492-499.

Edvinsson. Lars IH, and Povlsen GK (2011). Vascular plasticity in cerebrovascular disorders. Journal of Cerebral Blood Flow & Metabolism. 31, 15541571.

ElAli A, Theriault P, Rivest S. (2014). The Role of Pericytes in Neurovascular Unit Remodeling in Brain Disorders. Int. J. Mol. Sci 15: 6453-6474.

Emsley HC, Smith CJ, Gavin CM, Georgiou RF, Vail A, Barberan EM, et al. (2007). Clinical outcome followimg acute ischemic stroke relates to both activation and autoregulatory inhibition of cytokine production. BMC neurology 7:5.

Emsley HCA, Hopkins SJ. (2008). Acute ischemic stroke and infection: recent and emerging concepts. Lancet Neurol 7: 341-53.

Endres M et al. (2009). The Ischemic Cascade and Mediators of Ischemic Injury. In: Fisher M, editor. Handbook of clinical neurology. 92: 31-41.

Engel O, Meisel A. (2010).Models of infection before and after stroke: investigating new targets. Infect Disord Drug Targets 10:98-104.

Erta M, Quintana A, Hidalgo J . (2012). Interleukin-6, a major cytokine in the central nervous system. International journal of biological sciences 8(9): 1254-1266.

Famakinm, Bolanle M. (2014). The Immune Response to Acute Focal Cerebral Ischemia and Associated Post-stroke Immunodepression: A Focused Review. Aging and diseases 5(6): 307-326.

Fang H, Wang PF, Zhou Y, Wang YC, Yang QU. (2013). Toll-like receptor 4 signaling in intracerebral hemorrhage-induced inflammation and injury. Journal of Neuroinflammation 10:27.

Faralli A, Bigoni M, Mauro A,Rossi F, and Carulli D. (2013). Noninvasive Strategies to Promote Functional Recovery after Stroke. Hindawi Publishing Corporation Neural Plasticity.

Folyovich A, Bir E, Orbn C, Bajnok A, Varga V, Molnr AKB, Vsrhelyi B, Toldi G: Relevance of novel inflammatory markers in stroke-induced immunosuppression. BMC Neurology. 2014, 14:41

Font MA, Arboix A, Krupinski J. (2010). Angiogenesis, Neurogenesis and Neuroplasticity in Ischemic Stroke. Current Cardiology Reviews 6, 238-244.

Fouda AY, Kozak A, Alhusban A, Switzer JA and Fagan SA. (2013). Anti inflammatory IL-10 is upregulated in both hemispheres after experimental ischemic stroke: Hypertension blunts the response. Experimental & Translational Stroke Medicine, 5:12.

Francisco LM, Sage PT, Sharpe AH (2010) the PD-L pathway in tolerances and autoimmunity. Immunol Rev 236:219-42.

Frishman WH. (2003). Beta-Adrenergic Blockers. Circulation. 107: e117-9.

Gabriella P,Lovas G, Doboly A. (2014). Induction of Transforming Growth Factor Beta Receptors following Focal Ischemia in the Rat Brain. PLoS ONE 9(9): 1-15.

Gan Y, Liu Q, Wu W, et al. (2014). Ischemic neurons recruit natural killer cells that accelerate brain infraction. Cross Mark 111: 2704-2709.

Grate I, Bueno BG, Madrigal JLM, Caso JR, Alou L, Lus MLG, Leza JC. (2014). Toll-like 4 receptor inhibitor TAK-242 decreases neuroinflammation in rat brain frontal cortex after stress. Journal of Neuroinflammation 11:8.

Garlanda , Cecilia; Dinarello, Charles A. and Mantovani, Alberto. (2013). The Interleukin-1 Family: Back To The Future. Immunity 39(6): 10031018.

Garrido-Maraver J, Cordero; Oropesa-vila, Vega; Mata, Pavn; Miguel M, Calero; Paz, Cotn; Snchez-Alczar(2014). Coenzyme Q 10 Therapy. Mol Syndromol. 5:187197.

Gertz K, Kronenberg G, Balkaya M, Eom GD, Kalin RE, Laufs D, Dirnagl U, Heppner FL. (2012). Essential role of interleukin-6 in post-stroke Angiogenesis. Brain A Journal of Neurology 135; 19641980.

Gibson CL (2013). Cerebral ischemic stroke: is gender important?. Journal of Cerebral Blood Flow & Metabolism. 33, 13551361.

Golden et al. (2012). Human Umbilical Cord Blood Cells Alter Blood and Spleen Cell Populations After Stroke. Transl Stroke Res 3(4): 491499.

Golstein LB. (2001). Restorative therapy in stroke therapy. 2nd ed. London: Butterworth-Heinemann. p.365-366.

Gorsuch et al. (2012). The Complement System in Ischemia-Reperfusion Injuries. Immunobiology 217(11): 10261033.

Griffin, Gerald D; Charron, Dominique and Al-Daccak, Rheem. (2014). Post-traumatic stress disorder: revisiting adrenergics, glucocorticoids, immune system effects and homeostasis. Clinical & Translational Immunology 3 (27).

Gu L, Xiong X, Wei D, Gao X, Krams S, et al. (2013). T Cells Contribute to Stroke-Induced Lymphopenia in Rats. PLoS ONE 8(3).

Gupta YK, Chauhan A. (2011). Potential of immunosuppressive agents in cerebral ischaemia. Indian J Med Re 15-26.

Hallenbeck J. (2010). How inflammation modulates central nervous system vessel activation and provides targets for interventiona personal perspective. Ann N Y Acad Sci 1207: 17.

Hankey GJ. (2002). Stroke: Your Questions answered. Churchill Livingstone; 2002. h.69-76.

Horstman LL, Jy W, Ahn YS, Zivadinov R, Maghzi AH, Etemadifar M, Alexander JS, Minagar A. (2010). Role of platelets in neuroinflammation: a wideangle Perspective. Journal of Neuroinflammation 7:10.

Hsieh, Hsi-Lung; Wang, Hui-Hsin; Wu, Wen-Bin; Chu, Po-Ju; Yang, Chuen-Mao. (2010). Transforming growth factor-b1 induces matrix metalloproteinase-9 and cell migration in astrocytes: roles of ROS-dependent ERK- and JNKNF-B pathways. Journal of Neuroinflammation 7:88.

Hu Y, Zheng Y, Wu Y, Ni B, Shi S. (2014). Imbalance between IL-17A-Producing Cells and Regulatory T Cells during Ischemic Stroke. Mediators of Inflammation, 8 p.

Iadecola C and Anrather J. (2012). The immunology of stroke: from mechanisms to translation. Nat Med 17(7): 796808.

Jiang Y, Li L, Liu B, Zhang Y, Chen Q, et al. (2014) Vagus Nerve Stimulation Attenuates Cerebral Ischemia and Reperfusion Injury via Endogenous Cholinergic Pathway in Rat. PLoS ONE 9(7).

Jickling GC, Ander BP, Zhan X, Noblett D, Stamova B, et al. (2014). microRNA Expression in Peripheral Blood Cells following Acute Ischemic Stroke and Their Predicted Gene Targets. PloS ONE 9(6).

Jin R, Zhu X, Liu L, Nanda A, Granger N, Li G. (2013). Simvastatin attenuates stroke-induced splenic atrophy and lung suspectibility to spontaneous bacterial infection in mice. Stroke 44(4): 1135-1143.

Jonathan D, John A, Kerry O. (2014). Neuroinflammation and M2 microglia: the good, the bad, and the inflamed. Journal of Neuroinflammation. 11(98) 1-15.

Josefson E, Bergquist J, Ekman R, Tarkowski A. (1996). Catecholamines are synthesized by mouse lymphocytes and regulate function of these cells by induction of apoptosis. Immunology 88 140-146.

Kaito M, Araya S-I, Gondo Y, Fujita M, Minato N, et al. (2013). Relevance of Distinct Monocyte Subsets to Clinical Course of Ischemic Stroke Patients. PLoS ONE 8(8).

Kamel H, Ladecola C. (2012). Brain-Immune Interactions and Ischemic Stroke: Clinical Implications. Arch Neurol 69(5): 576581.

Kang SS, Keasey MP, Cai J, Hagg T. (2012). Loss of neuron-astroglial interaction rapidly induces protective CNTF expression after stroke in mice. J Neurosaci 32(27): 9277-9287.

Kasner SE et al. (1999). Reliability and validity of estimating the NIH stroke scale from medical records. Stroke. 30(8):1534-7

Keum S, Lee HK, Chu P-L, Kan MJ, Huang M-N, et al. (2013). Natural Genetic Variation of Integrin Alpha L (Itgal) Modulates Ischemic Brain Injury in Stroke. PLoS Genet 9(10).

Khanna et al. (2014). Effect of glibenclamide on the prevention of secondary brain injury following ischemic stroke in humans. Neurosurg Focus 36(1): E11.

Kikuchi; Uchikado; Morioka, Murai and Tanaka E (2012). Clinical Neuroprotective Drugs for Treatment and Prevention of Stroke. Int. J. Mol. Sci. 13: 7739-7761.

Kim et al. (2014). Innate inflammatory responses in stroke: mechanisms and potential therapeutic targets. Curr Med Chem 21(18): 20762097.

Kim JJ, Lee1 L, Park j. (2010). TNF-a-induced ROS production triggering apoptosis is directly linked to Romo1 and Bcl-XL. Cell Death and Differentiation. 17: 14201434.

Kishi T, Hirooka Y. (2012). Oxidative stress in the brain causes hypertension via symathoexcitation. Frontiers in Physiology 3:1-8.

Kurum T, Tatli E, Yuksel M. (2007). Effects of Carvedilol onPlasma Levels of Pro-Inflammatory Cytokines in Patients with Ischemic and Nonischemic Dilated Cardiomyopathy. Tex Heart Inst J 34:52-9.

Kwan J, Jenkinson D, Vassallo M, et al. (2008). Systemic infections after acute stroke. Future medicine 4(1):10.

Lakhan SE, Kirchgessner A, Tepper D, Leonard A. (2013). Matrix metalloproteinases and blood brain barrier disruption in acute ischemic stroke. Frontiers in Cellular Neuroscience 4(32) : 15.

Lambersten KL, Clausen BH, Babcock AA, Gregersen R, Fenger C, Nielsen HH, et al. (2009). Microglia protect neuroms againt ischemia by synthesis of tumor necrosis factor. The Journal of neuroscience: the official journal of the Society for Neuroscience 29:1319-1330.

Lambertsen KL, Clausen BH, Babcock AA, Gregersen R, Fenger C, Nielsen HH, Haugaard LS, Wirenfeldt M, Nielsen M, Hansen FD, Bluethmann H, Frgeman H, Meldgaard M, Deierborg T, Finsen BL. (2009). Microglia Protect Neurons against Ischemia by Synthesis ofTumor Necrosis Factor. The Journal of Neuroscience 29(5) : 1319 1330

Lambertsen, Kate Lykke; Biber, Knut and Finsen, Bente (2012). Inflammatory cytokines in experimental and human stroke. Journal of Cerebral Blood Flow & Metabolism 32:16771698

Lamsudin R. (1997). Gadjah Mada stroke algorithm. Dissertation for Doctorate Degree. Yogyakarta: Gadjah Mada University Indonesia.

Lee Y, Lee SR, Choi SS, Yeo HG, Chang KT, Lee HJ. (2014). Therapeutically Targeting Neuroinflammation and Microglia after Acute Ischemic Stroke. BioMed Research International 1-9.

Li G, Wang X, Huang L, Wang Y, Hao J, Ge X, Xu X. (2013). Cytotoxic function of CD8+ T lymphocytes isolated from patients with acute severe cerebral infarction: an assessment of stroke induced immunosuppression. BMC Immunology 14:1.

Li P, Gan Y, Sun BL, Zhang F, Lu B, Gao Y, Liang W, Thomson AW. (2013). Adoptive regulatory T cell therapy protects against cerebralIschemia. Ann Neurol 74(3): 458471.

Li, Jing; Song, Jie; Jiang Min-Hui; et al. (2012). Interleukin-6 Promoter Polymorphisms and Susceptibility to Atrial Fibrillation in Elderly Han Chinese Patientswith Essential Hypertension.

Liesz A, Suri-Prayer E, Veltkamp C, Doerr H, Sommer C, Rivest S, Giese T, Veltkamp R. (2009). Regulatory T cell are key cerebroprotective immunomodulators in acute experimetal stroke. Nat Med 15:192-9.

Liew SL, Santaamochhi E, Buch ER, Cohen LG. (2014). Non-invasive brain stimulation in neurorehabilitation: local and distant effects for motor recovery. Frontiers in Neurology 8:1-15.

Liu et al. (2014). Cell based therapies for ischemic stroke: From basic science toBedside. Prog Neurobiol 115: 92115.

Liu LP, Xu AD, Wong LK, Wang DZ, Wang YJ. (2014). Chinese Consensus Statement on the Evaluation and Intervention of Collateral Circulation for Ischemic Stroke. Neuroscience & Therapeutics 202208

Loftis JM, Huckans M, Morasco BJ. (2010). Neuroimmune mechanisms of cytokine-induced depression: Current theories and novel treatment strategies. Neurobiol Dis 37(3): 519533.

Lucin et al (2009). Stress Hormones Collaborate To Induce Lymphocyte Apoptosis After High Level Spinal Cord Injury. J Neurochem. 110(5): 14091421.

Lynch JR et al. (2004) Novel Diagnostic Test for Acute Stroke. Stroke. 35(1): 57-63.

Mallard C (2012). Innate Immune Regulation by Toll-Like Receptors in the Brain. International Scholarly Research Network ISRN Neurology.

Manwani et al. (2013). Differential effects of aging and sex on stroke induced inflammation across the lifespan. Exp Neurol 249.

Manzanero S, Gelderblom M, Magnus T, Arumugam TV. (2011). Calorie restriction and stroke. Experimental & Translational Stroke Medicine 3:8.

McCann SK, Roulston CL. (2013). NADPH Oxidase as a Therapeutic Target for Neuroprotection against Ischaemic Stroke: Future Perspectives. Brain Sciences 3: 561-598.

McCorry LK. (2007). Physiology of the Autonomic Nervous System. American Journal of Pharmaceutical Education 71 (4): 11.

Meschia JF, Worrall B, Rich S. (2014). Genetic susceptibility to ischemic stroke. Nat Rev Neurol 7(7): 369378.

Miao Y, and Liao JK. (2014). Potential serum biomarkers in the pathophysiological processes of stroke. Expert Rev Neurother 14(2): 173185.

Minnerup J, Sevimli S, Schabitz WF. (2009). Granulocyte-colony stimulating factor for stroke treatment: mechanisms of action and efficacy in preclinical studies. Experimental & Translational Stroke Medicine 1:2.

Minnerup J, Wersching H, Browinkel B, et al. (2011). The impact of lesion location and lesion size on post-stroke infection frequency. Experimental & Translational Stroke 1-21.

Mittal M, Siddiqul MR, Tran K, Reddy SP, Malik AB. (2014). Reactive Oxygen Species in Inflammation and Tissue Injury. Antioxidants & Redox Signaling 20(7): 42.

Morrison et al. (2011). The Contribution of Mannose Binding Lectin to Reperfusion Injury after Ischemic Stroke. Curr Neurovasc Res 8(1): 5263.

Mracsko E, Liesz A, Karcher S, et al. (2014). Differential effects of sympathetic nervous system and hypothalamic-pituitary-adrenal axis on systemic immune cells after severe experimental stroke. Brain Behav Immun 41:200-9.

Murray CL, Skelly DT, Cunningham D. (2011). Exacerbation of CNS inflammation and neurodegeneration by systemic LPS treatment isindependent of circulating IL-1b and IL-6. Journal of Neuroinflammation 8:50.

Nayaka AR, Kashyap RS, Kabra D, Purohit HJ, Taori GM, Daginawata HF. (2012). Time course of inflammatory Cytokines in acute ischemic stroke patients and their relation to inter-alfa trypsin inhibitor heavy chain 4 and outcome. Annals of Indian Academy of Neurology 15: 181-185.

Nour M, Scalzo F, Liebeskind DS. (2012). Ischemia-Reperfusion Injury in Stroke. Intervent Neurol 1:185199.

Offner H, and Hurn PD. (2012). A Novel Hypothesis: Regulatory B Lymphocytes Shape Outcome from Experimental Stroke. Transl Stroke Res 3(3): 324330.

Offner H, Subramanian S, Parker SM, Wang C, Afentoulis ME, Lewis A, Vandenbark AA, Hurn PD. (2006). Splenic athrophy in experimental stroke is accompanied by increased regulatory Tcell and circulating macrophages. Journal Immunol 176: 6523-31.

Offner H, Subramanian S, Parker SM, Afentoulis ME, Lewis A, Vandenbark AA, Hurn PD. (2006). Experimental stroke induced massive, rapid activation of the peripheral immune system. Journal Cerebral Blood Flow Metab 26: 654-65.

Ormstad, Heidi; Dalsbotten Aass, Hans Christian; Lund-Srensen, Niels; Amthor, Karl-Friedrich; Sandvik, Leif . (2011). Serum levels of cytokines and C-reactive protein in acute ischemic stroke patients, and their relationship to stroke lateralization, type, and infarct volume. J Neurol 258:677 685.

Ostrowski et al. (2012). Acute Splenic Irradiation Reduces Brain Injury in the Rat Focal Ischemic Stroke Model. Transl Stroke Res 3(4): 473481.

Pal G, Lovas G, Dobolyi, Arpad. (2014). Induction of Transforming Growth Factor Beta Receptorsfollowing Focal Ischemia in the Rat Brain. PLoS ONE 9(9).

Pai S, Danne KJ, Qin J, Cavanagh LL, Smith A, Hickey MJ, Wenniger W. (2013). Visualizing leukocyte trafficking in the living brain with 2-photon intravital microscopy. Frontiers in Cellular Neuroscience, 6(67):14.

Pandya RS, Mao L, Zhou H, Zou S, Zeng J, Popp AJ, Wang X. (2011). Central Nervous System Agents for Ischemic Stroke Neuroprotection Mechanisms. Cent Nerv Syst Agents Med Chem 11(2): 81-97.

Pappas et al. (2012). Transcriptional expression patterns triggered by chemically distinct neuroprotective molecules. Neuroscience 226: 1020.

Pavlov VA, Wang H, Czura CJ, et al. (2003). The Cholinergic Anti- Inflammatory Pathway :A Missing Link Neuroimmunomodulation. Molecular Medicine 9: 125-133.

Perez- de Puig I, Miro F, Salas-Perdomo A, Bonfill-Teixidor E, Ferrer-Ferrer M, Marquez Kisinousky L, et al. (2013). IL 10 deficiency exacerbates the brain inflammatory respone to permanent ischemia without preventing resolution of the lesion. Journal of cerebral blood flow and metabolism 33:1955-1966.

Perini F, Morra M, Alecci M, Galloni E, Marchi M, Toso V(2001). Temporal profile of serum anti inflammatory and pro- inflammatory interleukins in acute ischemic stroke patients. Neurological sciences. Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 22:289-296

Pettigrew LC, Kindy MS, Scheff S, Springer JE, Kryscio RJ, Li8 Y, Grass DS. (2008) Focal cerebral ischemia in the TNFalpha-transgenic rat.Journal of Neuroinflammation 5:47.

Pikula et al. (2012). Multiple Biomarkers and Risk of Clinical and Subclinical Vascular Brain Injury: The Framingham Offspring Study. Circulation 125(17): 21002107.

Pikula et al. (2013). Serum BDNF and VEGF levels are associated with Risk of Stroke and Vascular Brain Injury: Framingham Study. Stroke 44(10).

Planas AM, Gmez-Choco M, Urra X, Gorina R, Caballero M, Chamarro (2012) Brain-derived antigens in lyhmpoid tissue of patients with acute stroke. J Immunol 188: 2156-63

Prass K, Meisel C, Hoflich C, Braun J, Halle E, Wolf T, Ruscher K, Victorov IV, Priller J, Dirnagl U, Volk HD, Meisel A. (2003). Stroke-induced immunodeficiency promotes spontaneous bacterial infections and is mediated by sympathetic activation reversal by post stroke T helper cell type 1-like immunostimulation. J Exp Med 198:725-36.

Pulg IP, Miro F, Perdomo AS, Teixidor EB, Ferrer MF. (2013). IL-10 deficiency exacerbates the brain inflammatory response to permanent ischemia without preventing resolution of the lesion. Journal of Cerebral Blood Flow & Metabolism 33:19551966.

Quan Z,et al. (2015). Proteinprotein interaction network and mechanism analysis in ischemic stroke. Molecular Medicine reports 11: 29-36.

Rasouli J, Lekhraj R, Ozbalik M, Lalezari P, Casper D. (2011). Brain-Spleen Inflammatory Coupling A Literature Review. Einstein J Biol Med 27(2): 74-77.

Rasyid A, Soertidewi L. (2007). Managemen stroke komprehensif. p. 64-71.

Ren X, Akiyoshi K, Dziennis S, Vandenbark AA, Herson PS, Hurn PD, et al. (2011). Regulatory B cells limit CNS inflammation and neurologic deficit in murine experimental stroke. The Journal of neurosciences: the official journal of the Society for Neurosciences 31: 8556-8563.

Robert J de H. (1994). Clinimetrics in stroke. Amsterdam: the Departement of Neurology and the Departement of Clinical Epidemiology and Biostatistics. p.48-74

Ryu, Keun-Young;Cho, Geum-Sil; Piao, Hua Zi andKim, Won-Ki (2012). Role of TGF- in Survival of Phagocytizing Microglia: Autocrine Suppression of TNF- Production and Oxidative Stress. Experimental Neurobiology. (4):151-157.

R&D system. Tools for Cell Biology Research.

Sagar, Divya; Foss, Catherine; El Baz, Rasha; Pomper, Martin G.; Khan, Zafar K. And Jain, Pooja (2012). Mechanisms of Dendritic Cell Trafficking Across the Bloodbrain Barrier. J Neuroimmune Pharmacol 7(1): 7494.

Sakaguchi S, Sakaguchi N (2005) Regulatory T cells in immunologic self-tolerance and autoimmune disease. Int Rev Immunol 4: 330-6.

Savitz SI, Erhardt JA, Anthony JV, Gupta G, Xiang Li, Barone FC, Rosenbaum. (2000). The Novel B-Blocker, Carvedilol, Provides Neuroprotection in Transient Focal Stroke. The Journal of Cerebral Blood Flow and Metabolism 20(8): 1197-204.

Scheiermann, Christoph; Kunisaki, Yuya, and Frenette, Paul S. (2013). Circadian control of the immune system. Medicine Research 13(3): 190198.

Schulze J, Vogelgesang A, Dressel A. (2014). Catecholamines, Steroids and Immune Alterations in Ischemic Stroke and Other Acute Diseases. Aging and Disease 5: 327-339

Seifert HA, Hall AA, Chapman CB, Collier LA, Willing AE, Pennypacke. (2012). A Transient Decrease in Spleen ize Following Stroke Corresponds to Splenocyte Release into Systemic Circulation. J Neuroimmune Pharmacol 7(4): 1017-1024

Shaafi S, Sharifipour E, Rahmanifar R, Hejazi S, Andalib S, Nikanfar M, Baradarn B, Mehdizadeh R. (2014). Interleukin-6, a reliable prognostic factor for ischemic stroke. Iran J Neurol 13(2): 70-76.

Sharp, Frank R; Jickling, Glen C; Stamova, Boryana; Tian, Yingfang; Zhan, Xinhua; Liu, DaZhi; Kuczynski, Beth; Cox, Christopher D and Ander, Bradley P (2011). Molecular markers and mechanisms of stroke: RNA studies of blood in animals and humans. Journal of Cerebral Blood Flow & Metabolism. 31: 15131531.

Sharp FR et al. (2000). Review Article: Multiple molecular penumbras after focal cerebral ischemia. Jour of Cer Blood Flow and Metab. 20: 1011-32

Sheng W, Hu S, Hsiao T, et al. (2005). TNF- induced chemokine production and apoptosis in human neural precursor cells. Journal of Leukocyte Biology. (78): 1233-1241.

Shichita et al (2014). Post-ischemic inflammation regulates neural damage and protection. Frontiers in Cellular Neuroscience.

Shinozuka K, Dailey T, Tajiri N, Ishikawa H, Kaneko Yuji, Borlongan CV. (2013). Stem Cell Transplantation for Neuroprotection in Stroke. Brain Scencise 3, 239-261.

Singhal G, Jaehne Ej, Corrigan F, Baune BT. (2014). Cellular and molecular mechanisms of immunomodulation in the brain thourh environmrntal enrichment. Cellular Neuroscience 8, 1:29.

Smith, Craig J; Emsley, Hedley CA; Gavin, Carol M; et al. (2003). Peak plasma interleukin-6 and other peripheral markers of inflammation in the first week of ischaemic stroke correlate with brain infarct volume, stroke severity and long-term outcome. BMC Neurology 4:2.

Sonneville R,Verdonk F, Rauturier C, Klein IF, Wolff W, Annane D, Chretien F, Sharshar T. (2013). Understanding brain dysfunction in sepsis. Annals of Intensive Care 3:15.

Sorrells, Shawn F. and Sapolsky, Robert M. (2007). An Inflammatory Review of Glucocorticoid Actions in the CNS. Brain Behav Immun 21(3): 259272.

Sotgiu S, Zanda B, Marchetti B, Fois ML, Arru G, Pes GM, et al. (2006). Inflammatory biomarker in blood of patients with acute brain ischemia. European journal of neurology: the official journal of the European Federation of Neurological Societies 13:505-513.

Stamova B, Tian Y, Jickling G, Bushnell C, Zhan Xinhua, Liu D, Ander BP, Verro P, Jauch EC, Pancioli A, Sharp FR. (2012). The X-chromosome has a different pattern of gene expression in women compared to men with ischemic stroke. Stroke 43(2): 326334.

Surjawan Y et al. (2013). The Different Pattern of Blood S100B Protein and GFAP Concentrations in Ischemic Stroke. 22:4. P. 215-20.

Tarkowski E et al. (1997). Intrathecal Release of Pro- and Antiinflammatory Cytokines during Stroke. Clin Exp Immunol. 110(3):492-9.

Taylor RA, and Sansing LH. (2013). Microglial Responses after Ischemic Stroke and Intracerebral Hemorrhage. Hindawi Publishing Corporation Clinical and Developmental Immunology.

Thorvaldsen P et al. 1995. Stroke incidence, case fatality, and mortality in the WHO MONICA Project. Stroke. 1995;26:361-67.

Thygarajan S, Priyanka HP. (2012). Bidirectional communication between the neuroendocrine system and the immune system: relevance to health and diseases. Annals of neurosciences, 19(1):7.

Toole JF. (1999). Applied Physiology of the cerebral circulation. In: Toole JF. Cerebrovascular disorders. p. 28-49.

Truelsen T, Bonita R (2009). The worldwide burden of stroke: current status and future projection. In: Fischer M (ed). Handbook of Clinical Neurology vol.92. Stroke, part I 16: 327-334

Turtzo et al. (2013). Deletion of Macrophage Migration Inhibitory Factor Worsens Stroke Outcome in Female Mice. Neurobiol Dis 54: 421431.

Tuttolumondo A, Pecoraro R, Pinto A. (2014). Studies of selective TNF inhibitors in the treatment of brain injury from stroke and trauma: a review of the evidence to date. Drug Design, Development and Therapy 8 22212239.

Urra X, Cervera , Obach V, Climent N, Chammorro . (2009). Monocytes are major players in the prognosis and risk of infection after acute stroke. Stroke 40: 1262-8.

Urra X, Miro F, Chamorro A, Planas AM. (2014). Antigen-specific immune reactions to ischemic stroke. Frontiers in Cellular Neuroscience 8(278) : 15.

Vemuganti R. (2013). Alls Well That Transcribes Well: Non-coding RNAs and Post- Stroke Brain Damage. Neurochem Int 63(5): 438449.

Villa P, Bigini P, Mennini T, Agnello D, Laragione T. (2003). Erythropoietin Selectively Attenuates Cytokine Production and Inflammation in Cerebral Ischemia by Targeting Neuronal Apoptosis. J. Exp. Med 6:971-975.

Vogelgesang A, May VEL, Grunwald U, Bakkeboe M, Langner S, et al. (2010). Functional Status of Peripheral Blood T-Cells in Ischemic Stroke Patients. PLoS ONE 5(1).

Vojdani A, Lamber J, Kellermann G. (2011). The Role of Th17 in Neuroimmune Disorders: A Target for CAM Therapy. Part III. Hindawi Publishing Corporation Evidence-Based Complementary and Alternative Medicine 11: 1-11.

Warlow CP et al. (2007). Stroke a practical guide to management. p. 637-42.

Waschek JA. (2013). VIP and PACAP: neuropeptide modulators of CNS inflammation, injury, and repair. British Journal of Pharmacology 169: 512523.

Watters O, OConnor J. (2011). A role for tumor necrosis factor-a in ischemia and ischemic preconditioning. Journal of Neuroinflammation 8:87.

White RE, Palm Q, Xu L, Ling E, Ginsburg M, Daigle BJ, Han R, Patterson A. (2012). Mice lacking the b2 adrenergic receptor have a unique genetic profile before and after focal brain ischaemia. Asn Neuro 4(5):14.

White BJ, Tarabishy S, Venna, Venugopal R, Manwani B, Benashski S, McCullough, Louise D. Li, Jun. (2012). Protection from Cerebral Ischemia by Inhibition of TGF-activated kinase. Exp Neurol 237(1): 238245.

Winklewski PJ, Radkowski M, Demkow, Urszula. (2014). Cross-talk between the inflammatory response, sympathetic activation and pulmonary infection in the ischemic stroke. Journal of Neuroinflammation 11:213.

Woiciechowsky C et al. (1999). Catecholamine-induced interleukin-10 release: a key mechanism in systemic immunodepression after brain injury. Crit Care. 3: R107-11.

Woodcock T, Morganti MC. (2013). The role of markers of inflammation in traumatic brain injury. Frontiers in Neurology 1:18.

Woodruff TM, Thundyil J, Tang SC, Sobey CG, Taylor SM, Arumugam TV. (2011) Pathophysiology, treatment, and animal and cellular models of human ischemic stroke. Molecular Neurodegeneration 6:11.

Wu H, Li L, Su X. (2014). Vagus Nerve through 7 nAChR Modulates Lung Infection and Inflammation: Models, Cells, and Signals. BioMed Research International 1:20.

Wunderlich MT et al. (1999). Early Neurobehavioral Outcome After Stroke is Related to Release of Neurobiochemical Markers of Brain Damage. 30(6):1190-5.

Xie G, Myint PK, Zaman MJS, Li Y, Zhao L, et al. (2013). Relationship of Serum Interleukin-10 and Its Genetic Variations with Ischemic Stroke in a Chinese General Population. PLoS ONE 8(9).

Xin et al. (2011). IL-10 within the CNS is necessary for CD4+ T cells to mediateNeuroprotection. Brain Behav Immun 25(5): 820829.

Xin H, Chopp M, Shen LH, Zhang RL, Zhang L, Zhang, Zheng G, Li Y. (2013). Multipotent mesenchymal stromal cells decrease transforming growth factor 1 expression in microglia/macrophages anddown-regulate plasminogen activator inhibitor 1 expression inastrocytes after stroke. Neurosci Lett 542: 8186.

Xing C, Arai K, Hommel M. (2012). Pathophysiologic cascades in ischemic stroke. Int J Stroke 7(5): 378385.

Xiong F, Zhang L. (2013). Role of the Hypothalamic-Pituitary-Adrenal Axis in Developmental Programming of Health and Disease. Front Neuroendocrinol 34(1): 27-46

Xiong X, Barreto G, Xu L, Ouyang Y, Xie X, Giffard RG. (2011). Increased brain injury and worsened neurological outcome in IL-4 Knockout Mice Following Transient Focal Cerebral Ischemia. Stroke. 42(7): 20262032.

Xu X, Jiang Y. (2014). The yin and yang of innate immunity in stroke. BioMed Research International 1:8.

Yadav S, Hasan N, Marjot T, Khan MS, Prasad K, et al. (2013). Detailed Analysis of Gene Polymorphisms Associated with Ischemic Stroke in SouthAsians. PLoS ONE 8(3): 1-8.

Yan F.-L. et al. (2014). Role of the Sympathetic Nervous System and Spleen in Experimental Stroke Induced Immunodepression. Med Sci Monit 20: 2489-2496.

Yilmaz G, Arumugam TV, Strokes KY, Granger DN (2006) Role of T lmphosytes and interferon in ischemic stroke. Circulation 113:2015-12.

Yin KJ, Hamblin M, Chen YE. (2014). Angiogenesis-regulating microRNAs and ischemic stroke. Curr Vasc Pharmacol, 1:27.

Yousuf et al. (2013). Post-Stroke Infections Exacerbate Ischemic Brain Injury in Middle-Aged Rats: Immunomodulation and Neuroprotection by Progesterone. Neuroscience 239: 92102.

Yu CY, Ng G, Liao PL. (2013). Therapeutic Antibodies in Stroke. Stroke Res. 4:477483.

Zang Q, Raoof M, Chen Y, Sumi Y, Sursal T, Junger W, et al. (2010). Circulating mitochondrial DAMPs cause inflammatory responses to injury. Nature 464: 104-107.

Zhang et al. (2014). Accumulation of natural killer cells in ischemic brain tissues and the chemotactic effect of IP-10. Journal of Neuroinflammation 11:79.

Zi W-J, Shuai J. (2013). Cortisol as a Prognostic Marker of Short-Term Outcome in Chinese Patients with Acute Ischemic Stroke. PLoS ONE 8:9.

Zubcevic et al. (2012). Autonomic-Immune-Vascular Interaction: An Emerging Concept for Neurogenic Hypertension. Hypertension 57(6): 10261033.

Zucchi F, Matthies N, Badr N. (2010). Stress-induced glucocorticoid receptor activation determines functional recovery following ischemic stroke. Experimental & Translational Stroke Medicine 2-18.

96